Investment Memo

Vitalis Loop

Chloe Martin (@chloemartin_md) · Continuous post-op recovery monitoring from wearables, triaged straight to the care team.

WATCHSignal → decision: 26h

Trust Ledger

3 verified0 claimed0 contradicted

Every claim in this memo, checked against how well it holds up.

Company Snapshot

What the company does and where it sits in the market.

Vitalis Loop operates in Health AI (Copenhagen, DK, Pre-seed). Continuous post-op recovery monitoring from wearables, triaged straight to the care team. Remote post-op monitoring has emerging reimbursement codes in several markets; regulatory tailwind is real but adoption cycles are long.

Investment Hypotheses

The core bets underlying this memo, each traced to its evidence.

Team quality: Practicing surgeon who has been prototyping on real post-op patients for a year before raising; understands the regulatory path better than most fintech-style movers-fast founders would in this domain.^{⟦ev-cm-pilot⟧}
Market wedge: Remote post-op monitoring has emerging reimbursement codes in several markets; regulatory tailwind is real but adoption cycles are long.
Traction signal: Completed hospital pilot with outcomes data^{⟦ev-cm-pilot⟧}VERIFIED
Defensibility: Idea survives; clinical credibility and CE-mark progress reduce the usual health-AI trust deficit.^{⟦ev-cm-ce⟧}
Founder credibility: Practicing surgeon, 9 years post-op careVERIFIED

SWOT

Strengths, weaknesses, opportunities, threats — shown only where evidence exists.

Strengths

Delegate-an-Analyst: Caught the planted error and flagged an additional clinical-risk nuance the brief missed entirely.
Steelman-Your-Rival: Precisely mapped the two hospital-system incumbents and why the wearable-first angle beats them on cost.
Revelation Menu: Chose the milestone-tied offer pegged to a second hospital pilot — specific and falsifiable.

Opportunities

Founder axis improving: Practicing surgeon who has been prototyping on real post-op patients for a year before raising; understands the regulatory path better than most fintech-style movers-fast founders would in this domain.^{⟦ev-cm-pilot⟧}
Market axis improving (bullish): Remote post-op monitoring has emerging reimbursement codes in several markets; regulatory tailwind is real but adoption cycles are long.

Problem & Product

The problem being solved and how the product addresses it.

Problem: Remote post-op monitoring has emerging reimbursement codes in several markets; regulatory tailwind is real but adoption cycles are long.

Product: Continuous post-op recovery monitoring from wearables, triaged straight to the care team. Idea survives; clinical credibility and CE-mark progress reduce the usual health-AI trust deficit.

Traction & KPIs

Traction and revenue signals, with unverified gaps flagged explicitly.

Completed hospital pilot with outcomes data^{⟦ev-cm-pilot⟧}VERIFIED
ARR: not applicable — pre-revenue stage
Cap table: not disclosed
Financials / P&L: unavailable at this stage

2 sourcesbehind the citations above — duplicates the inline ⟦refs⟧, expand to inspect the raw excerpt.

Three-Axis Verdict

never averaged

Founder, market, and idea-fit scored independently — one weak axis can't be masked by a strong one.

Founder

74improving

Market

68improving

BULLISH

Idea × Market

70stable

Rigorous, clinically credible, and regulatory progress is real, but adoption-cycle length warrants one more pilot before committing capital.

The Closer

$100K Check

The investment decision itself — deploy, hold, or decline — with every number traced to a receipt.

Maschmeyer Group2026-07-22

Pay to the order of

Chloe Martin / Vitalis Loop

$100,000

One Hundred Thousand Dollars

Memo · Pre-seed · Maschmeyer Group

Held — pending one signal: Rigorous, clinically credible, and regulatory progress is real, but adoption-cycle length warrants one more pilot before committing capital.

Evidence trace

Armed and waiting — receipts surface the moment you deploy.

PROOF ENGINE · STANDBY